Guide · 3 min read

Proactive Care Scheme 2026/27: what PCNs need to know

£40 million to keep the patients most at risk out of hospital this winter. Here's who it covers, what each plan must include, and how medicines fit in.

Checked against the sources listed at the end on .

Clinically reviewed by Aisha Malik, Clinical Director (GPhC 2205843), on .

The short answer

On 9 November 2026 the government announced £40 million for general practice this winter, to help keep the patients most at risk out of hospital. Primary care networks (PCNs) can receive £126 for each eligible patient supported, and the government says up to 300,000 people could be helped.

The money comes through a new Proactive Care Scheme in the 2026/27 Network Contract Directed Enhanced Service (DES). Each PCN identifies the patients at greatest risk of an avoidable hospital admission this winter, carries out a holistic assessment of their needs and agrees a personalised Proactive Care Plan with each one. NHS England's guidance sets each PCN's limit at 0.5% of its adjusted population as at 1 July 2026. There's no minimum number of patients.

Medicines sit at the centre of this work. Medication optimisation and falls prevention are among the interventions the guidance lists for each plan.

Which patients the scheme covers

NHS England's guidance targets the 0.5% of a PCN's patients at greatest risk of an avoidable winter hospital admission. It gives these examples:

  • people living with moderate or severe frailty
  • people with chronic obstructive pulmonary disease (COPD) or other severe respiratory disease
  • people with Heart Failure

PCNs choose their patients using local data, the electronic frailty index (eFI), clinical validation tools and local knowledge. The guidance says further prioritisation by risk may be needed, depending on local capacity.

What the needs assessment covers

For each patient, the guidance describes a holistic needs assessment that looks at:

  • their personal and social circumstances
  • their medical history and current health and wellbeing needs
  • mental capacity, where relevant
  • whether an assessment under the Care Act 2014, or for NHS Continuing Healthcare, should be considered
  • whether a carer's assessment and a carer support plan are needed

The assessment must involve the patient and/or their registered carer.

What the Proactive Care Plan must do

There's no national template, and the plan doesn't need the commissioner's approval. It does need to meet five criteria set out in the guidance:

  1. The patient is central to developing and agreeing the plan.
  2. The patient has proactive, personalised conversations about what matters to them.
  3. The patient agrees health and wellbeing outcomes with the professionals involved.
  4. There's a sharable plan recording their priorities, outcomes and interventions.
  5. The patient can review the plan, formally and informally.

Interventions can include medication optimisation, falls prevention, a Comprehensive Geriatric Assessment, ReSPECT and anticipatory care planning, social prescribing and carer support, tailored to each person. PCNs can involve community services, social care, specialist services and voluntary organisations.

Why medicines matter for these patients

The National Audit Office reported in December 2025 that 226,000 people were diagnosed with severe frailty in 2024-25. Of those, 16% (37,000) had a medication review and 18% (41,000) had a falls risk assessment.

For people in the community who need falls management, NICE's falls guideline (NG249) recommends considering a structured medication review, to find medicines that may raise that risk and consider adjusting them. For people taking psychotropic medicines, it recommends reviewing them, discussing the increased risk of falls with the person and planning withdrawal as appropriate.

NHS England's DES guidance already asks PCNs to prioritise structured medication reviews for people with severe frailty who are isolated or housebound, or who have recently been in hospital or had a fall, and for people on 10 or more medicines. For many patients on a Proactive Care list, a structured medication review is the natural place to start.

Where a clinical pharmacist helps

The guidance doesn't say which professionals must carry out the assessment or the plan, so PCNs can build the team that suits them. A clinical pharmacist can take on the medicines side:

  • structured medication reviews for the patients on your Proactive Care list, with the patient and their carer
  • medicines that raise the risk of falls, confusion or anticholinergic burden looked at first
  • medicines that no longer help stopped safely, with a plan for anything reduced gradually (see problematic polypharmacy and deprescribing)
  • findings written into the patient's Proactive Care Plan, so the rest of the team can see them
  • anything that needs a GP's decision flagged clearly

Clinical pharmacists are one of the roles PCNs can fund through the Additional Roles Reimbursement Scheme (ARRS). We place remote clinical pharmacists with PCNs for this kind of work, and every session is logged in ReportRx. See frailty reviews.

Recording the work

NHS England's guidance asks PCNs to record qualifying activity in the patient record using the SNOMED codes in its appendix, including 934231000000106 (provision of proactive care) and 934691000000105 (proactive care ended). A structured medication review is coded 1239511000000100. NHS England's guidance points to section 10.7 of the updated DES specification for the payment rules.

Questions people ask

What is the Proactive Care Scheme?

A winter 2026/27 addition to the Network Contract DES. Each PCN identifies the patients at greatest risk of an avoidable hospital admission this winter, carries out a holistic needs assessment and agrees a personalised Proactive Care Plan with each one. The government has put £40 million behind it.

How much does a PCN get?

The government says PCNs can receive £126 for each eligible patient supported. NHS England's guidance limits each PCN to 0.5% of its adjusted population as at 1 July 2026, and there's no minimum number of patients.

Which patients are eligible?

The patients a PCN judges to be at greatest risk of an avoidable winter admission. NHS England's examples are people with moderate or severe frailty, COPD or other severe respiratory disease, and Heart Failure. PCNs use local data, the electronic frailty index, clinical validation and local knowledge to choose them.

Does the care plan need a template or commissioner approval?

No. NHS England doesn't mandate a template and the plan doesn't need the commissioner's approval, but it must meet five criteria: the patient is central to it, has personalised conversations, agrees outcomes, has a sharable plan and can review it.

Can a clinical pharmacist do the work?

The guidance doesn't say which professionals must do it. Medication optimisation and falls prevention are among the listed interventions, and a clinical pharmacist can carry out structured medication reviews for the patients on the list. Clinical pharmacists are one of the roles PCNs can fund through ARRS.

Sources

  1. £40 million for GPs to keep vulnerable patients out of hospital this winter, 9 November 2026 (GOV.UK)
  2. Network Contract DES 2026/27, Part A guidance: clinical and support services (section 8), 9 November 2026 (NHS England)
  3. Network Contract DES: contract specification 2026/27, updated November 2026, section 10.7 (NHS England)
  4. Primary and community healthcare support for people living with frailty, press release, 5 December 2025 (National Audit Office)
  5. Falls: assessment and prevention in older people and in people 50 and over at higher risk, NICE guideline NG249, recommendations
  6. Network Contract DES: contract specification 2026/27, section 7, Additional Roles Reimbursement Scheme (NHS England)

More guides

All guides